Case Report: Mustardé Flap Perfom for Reconstruction of the Cheek in a Patient with Basal Cell Carcinoma in a Second Level of Care

Main Article Content

José Alfredo Villanueva López
Alejandro Álvarez Padilla
María de los Ángeles Martínez Ferretiz
Daniel Alejandro Martínez del Ángel
José Arturo Estrada González

Abstract

Basal cell carcinoma is the most common type of skin cancer, originating in the basal cells of the epidermis, the outermost layer of skin. It typically develops in areas frequently exposed to the sun, such as the face, neck, and arms.


BCC grows slowly and rarely metastasizes to other parts of the body, but if left untreated, it can cause significant local tissue damage.


It is present as a pearly or waxy bump, often with visible blood vessels. It may algo appear as a flat, scaly patch, sometimes with a rolled border.


Risk factors include prolonged UV exposure, fair skin a history of sunburns, and weakened immune system.
Treatment options include surgical excision, Mohs surgery, topical therapies, radiation, depending on the size, depth, and location of the tumor.
Prevention involves regular sun protection, such as using sunscreen and avoiding excessive sun exposure

Article Details

How to Cite
Villanueva López, J. A., Alejandro Álvarez Padilla, María de los Ángeles Martínez Ferretiz, Daniel Alejandro Martínez del Ángel, & José Arturo Estrada González. (2024). Case Report: Mustardé Flap Perfom for Reconstruction of the Cheek in a Patient with Basal Cell Carcinoma in a Second Level of Care. International Journal of Medical Science and Clinical Research Studies, 4(11), 2036–2041. https://doi.org/10.47191/ijmscrs/v4-i11-16
Section
Articles

References

I. Jacob, A (1827). Observations respecting an ulcer of peculiar character, which attacks the eyelids and other parts of the face. Dublin Hospital Reports, 4, 232-239.

II. Herrera-Acosta, E. (2003). Carcinoma basocelular: concepto e historia. Monografías de Dermatología, 16, 65–66

III. Mohs, F.E. (1941). Chemosurgery: A microscopically controlled method of cancer excision. Archives of surgery, 42 (2), 279-295.

IV. Ricotti, C., Bouzari, N., Agadi, A., & Cockerell, C. J. (2009). Malignant skin neoplasms. The Medical Clinics of North America, 93(6), 1241–1264. https://doi.org/10.1016/j.mcna.2009.08.011

V. Kauvar, A. N. B., Cronin, T., Jr, Roenigk, R., Hruza, G., Bennett, R., & American Society for Dermatologic Surgery. (2015). Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatologic Surgery, 41(5), 550–571.

https://doi.org/10.1097/DSS.0000000000000296

VI. Lomas, A., Leonardi-Bee, J., & Bath-Hextall, F. (2012). A systematic review of worldwide incidence of nonmelanoma skin cancer: Worldwide incidence of nonmelanoma skin cancer. The British Journal of Dermatology, 166(5), 1069–1080.

https://doi.org/10.1111/j.13652133.2012.10830.x

VII. Bisceglia, M., Panniello, G., Galliani, C. A., Centola, M., D’Errico, M. M., Minenna, E., Tucci, F. A., & Ben-Dor, D. J. (2020). Metastatic basal cell carcinoma of the skin: A comprehensive literature review, including advances in molecular therapeutics. Advances in Anatomic Pathology, 27(5), 331–353. https://doi.org/10.1097/PAP.0000000000000267

Arits, A. H. M. M., Schlangen, M. H. J., Nelemans, P. J., & Kelleners-Smeets, N. W. J. (2011). Trends in the incidence of basal cell carcinoma by histopathological subtype: Incidence of basal cell carcinoma. Journal of the European Academy of Dermatology and Venereology: JEADV, 25(5), 565–569. https://doi.org/10.1111/j.1468-3083.2010.03839.x

VIII. Madan, V., Lear, J. T., & Szeimies, R.-M. (2010). Non-melanoma skin cancer. Lancet,

(9715), 673–685.

https://doi.org/10.1016/S0140-6736(09)61196-X

IX. Karia, P. S., Ward, B., & Han, J. (2020). Basal cell carcinoma: A comprehensive review. J Am Acad Dermatol, 82(4), 961–983.

X. Alsaif, A., Hayre, A., Karam, M., Rahman, S., Abdul, Z., & Matteucci, P. (2021). Mohs micrographic surgery versus standard excision for basal cell carcinoma in the head and neck: Systematic review and meta-analysis. Cureus, 13(11), e19981.https://doi.org/10.7759/cureus.19981

Lucas Fuenzalida M. Keilo Villalobos C. Rodrigo Miranda P. Patricio Cabané T. (2023). Colgajo de Mustardé como tratamiento de un carcinoma basocelular. A propósito de un caso. Rev. Cir, 307–313.

XI. Vílchez-Márquez, F., Borregón-Nofuentes, P., Barchino-Ortiz, L., Ruíz-de-Casas, A., Palacios-Álvarez, I., Soria-Rivas, A., Descalzo-Gallego, M. A., García-Doval, I., Ríos-Buceta, L., & Redondo-Bellón, P. (2020). Carcinoma basocelular cutáneo: diagnóstico y tratamiento en atención especializada dermatológica. Guía de Práctica Clínica de la AEDV. Actas Dermo-Sifiliograficas, 111(4), 291–299. https://doi.org/10.1016/j.ad.2019.07.006

XII. Ciążyńska, M., Kamińska-Winciorek, G., Lange, D., Lewandowski, B., Reich, A., Sławińska, M., Pabianek, M., Szczepaniak, K., Hankiewicz, A., Ułańska, M., Morawiec, J., Błasińska-Morawiec, M., Morawiec, Z., Piekarski, J., Nejc, D., Brodowski, R., Zaryczańska, A., Sobjanek, M., Nowicki, R. J., … Lesiak, A. (2021). The incidence and clinical analysis of non-melanoma skin cancer. Scientific Reports, 11(1), 4337. https://doi.org/10.1038/s41598-021-83502-8

XIII. Gulleth, Y., Goldberg, N., Silverman, R. P., & Gastman, B. R. (2010). What is the best surgical margin for a Basal cell carcinoma: a meta-analysis of the literature. Plastic and Reconstructive Surgery, 126(4), 1222–1231. https://doi.org/10.1097/PRS.0b013e3181ea450d

Similar Articles

You may also start an advanced similarity search for this article.